Spironolactone Tablet, Film Coated
Product Images NDC 63629-5341

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-5341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

FDA Label Image

Figure 2 (Spironolactone 03)

This appears to be a medical chart or graph that shows the results of a study comparing the effectiveness of Spironolactone versus a placebo in treating diabetes patients with high potassium and creatinine levels. The chart includes various data and measurements such as subgroup, heart rate, potassium levels, and beta-blocker usage. It also includes a graph which visualizes the comparison between Spironolactone and placebo. Not available.*

FDA Label Image

Label Image (Lbl636295341)

This is a package of Spironolactone tablets produced by Bryant Ranck Prepack Bunbauk. These round white tablets are substitutes for Aldactone 50mg Tablet manufactured by Frontida BioPharm, Inc. The tablets come in a bottle of 30 and have an expiration date indicated as MM/YY. It is recommended to store the medication at room temperature between 20°-25°C (68°-77°F) out of reach of children. The National Drug Code (NDC) number for this package is 6362953411 05341301523487.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.